{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:00:44Z","timestamp":1791896444098,"version":"4.3.4"},"reference-count":291,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":2421,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.bbamem.2006.05.027","type":"journal-article","created":{"date-parts":[[2006,6,15]],"date-time":"2006-06-15T12:43:27Z","timestamp":1150375407000},"page":"2057-2079","source":"Crossref","is-referenced-by-count":334,"title":["Sphingolipid metabolism diseases"],"prefix":"10.1016","volume":"1758","author":[{"given":"Thomas","family":"Kolter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Sandhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamem.2006.05.027_bib1","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/(SICI)1521-3773(19990601)38:11<1532::AID-ANIE1532>3.0.CO;2-U","article-title":"Sphingolipids\u2014Their metabolic pathways the pathobiochemistry of neurodegenerative diseases","volume":"38","author":"Kolter","year":"1999","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.bbamem.2006.05.027_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1146\/annurev.bi.50.070181.003505","article-title":"Glycosphingolipids in cellular interaction, differentiation, oncogenesis","volume":"50","author":"Hakomori","year":"1981","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0092-8674(03)00882-1","article-title":"Lipid rafts: elusive or illusive?","volume":"115","author":"Munro","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bbamem.2006.05.027_bib4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tibs.2005.06.004","article-title":"Detergent-resistant membranes should not be identified with membrane rafts","volume":"30","author":"Lichtenberg","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbamem.2006.05.027_bib5","doi-asserted-by":"crossref","first-page":"17221","DOI":"10.1074\/jbc.R000005200","article-title":"Structure function of sphingolipid-cholesterol-rich membrane rafts","volume":"275","author":"Brown","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib6","doi-asserted-by":"crossref","first-page":"25855","DOI":"10.1074\/jbc.R200010200","article-title":"Sphingolipid transport: rafts translocators","volume":"277","author":"van Meer","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1034\/j.1600-0854.2000.011007.x","article-title":"Biomolecule function: no reliable prediction from cell culture","volume":"1","author":"Kolter","year":"2000","journal-title":"Traffic"},{"key":"10.1016\/j.bbamem.2006.05.027_bib8","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1073\/pnas.93.2.814","article-title":"Gangliosides are neuronal ligands for myelin-associated glycoprotein","volume":"93","author":"Yang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/glycob\/3.2.97","article-title":"Biological roles of oligosaccharides: all of the theories are correct","volume":"3","author":"Varki","year":"1993","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbamem.2006.05.027_bib10","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1073\/pnas.0635898100","article-title":"Enhanced insulin sensitivity in mice lacking ganglioside GM3","volume":"100","author":"Yamashita","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0009-3084(97)00108-4","article-title":"The physical, chemical functional properties of lipids in the skin other biological barriers","volume":"91","author":"Wertz","year":"1998","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bbamem.2006.05.027_bib12","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0022-2275(20)39952-1","article-title":"6-Hydroxy-4-sphingenine in human epidermal ceramides","volume":"35","author":"Robson","year":"1994","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbamem.2006.05.027_bib13","doi-asserted-by":"crossref","first-page":"17763","DOI":"10.1074\/jbc.273.28.17763","article-title":"Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope","volume":"273","author":"Marekov","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1567269053390239","article-title":"Sphingolipids as emerging drug targets","volume":"2","author":"Wendeler","year":"2005","journal-title":"Drug Des. Rev. -Online"},{"key":"10.1016\/j.bbamem.2006.05.027_bib15","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1073\/pnas.78.9.5406","article-title":"Specific gangliosides function as host cell receptors for Sendai virus","volume":"78","author":"Markwell","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.bi.58.070189.001521","article-title":"Animal glycosphingolipids as membrane attachment sites for bacteria","volume":"5","author":"Karlsson","year":"1989","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-5793(02)03182-4","article-title":"Transport of protein toxins into cells: pathways used by ricin, cholera toxin Shiga toxin","volume":"529","author":"Sandvig","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamem.2006.05.027_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.7883\/yoken.JJID.2005.131","article-title":"Sphingolipids in infectious diseases","volume":"58","author":"Hanada","year":"2005","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.bbamem.2006.05.027_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1286-4579(02)01550-2","article-title":"Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of Guillain\u2013Barr\u00e9 syndrome","volume":"4","author":"Schwerer","year":"2002","journal-title":"Microbes Infect."},{"key":"10.1016\/j.bbamem.2006.05.027_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1473-3099(01)00019-6","article-title":"Infectious origins of, and molecular mimicry in, Guillain\u2013Barr\u00e9 and Fisher-syndromes","volume":"1","author":"Yuki","year":"2001","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbamem.2006.05.027_bib21","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1016\/S0040-4039(00)73889-5","article-title":"Agelasphins, novel \u03b1-galactosylceramides from the marine sponge Agelas mauritianus","volume":"34","author":"Natori","year":"1993","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bbamem.2006.05.027_bib22","first-page":"31","article-title":"\u03b1-galactosylceramide therapy for autoimmune diseases: prospects and obstacles","volume":"5","author":"van Kaer","year":"2005","journal-title":"Nat. Rev."},{"key":"10.1016\/j.bbamem.2006.05.027_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.tips.2005.03.005","article-title":"Immunotherapeutic potential for ceramide-based activators of iNKT cells","volume":"26","author":"Berkers","year":"2005","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.bbamem.2006.05.027_bib24","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1126\/science.1103440","article-title":"Lysosomal glycosphingolipid recognition by NKT cells","volume":"306","author":"Zhou","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbamem.2006.05.027_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ijc.20851","article-title":"Implications of galactocerebrosidase and galactosylcerebroside metabolism in cancer cells","volume":"115","author":"Beier","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbamem.2006.05.027_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1043-6618(03)00050-1","article-title":"Intracellular signal transduction pathways activated by ceramide its metabolites","volume":"47","author":"Ruvolo","year":"2003","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbamem.2006.05.027_bib27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1388-1981(02)00154-3","article-title":"Sphingosylphosphorylcholine-biological functions and mechanisms of action","volume":"1582","author":"Meyer zu Heringdorf","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2006.05.027_bib28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nri1650","article-title":"Sphingosine-1-phosphate and its receptors: an autocrine and paracrine network","volume":"5","author":"Rosen","year":"2005","journal-title":"Nat. Rev., Immunol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib29","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1242\/jcs.02637","article-title":"Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling","volume":"118","author":"Chalfant","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbamem.2006.05.027_bib30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbamem.2006.05.027_bib31","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/ejoc.200200518","article-title":"Bioorganic chemistry of ceramide","author":"Brodesser","year":"2003","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib32","doi-asserted-by":"crossref","first-page":"41125","DOI":"10.1074\/jbc.R500015200","article-title":"Lipid binding proteins in membrane digestion, antigen presentation and antimicrobial defense","volume":"280","author":"Kolter","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib33","doi-asserted-by":"crossref","first-page":"25843","DOI":"10.1074\/jbc.R200009200","article-title":"De novo sphingolipid biosynthesis: a necessary, but dangerous pathway","volume":"277","author":"Merrill","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib34","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature02188","article-title":"Molecular machinery for non-vesicular trafficking of ceramide","volume":"426","author":"Hanada","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbamem.2006.05.027_bib35","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.1074\/jbc.M305645200","article-title":"Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis","volume":"279","author":"De Rosa","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1042\/BJ20050047","article-title":"The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids","volume":"389","author":"Eckford","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamem.2006.05.027_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1023\/A:1020271932760","article-title":"Understanding the stepwise synthesis of glycolipids","volume":"27","author":"Maccioni","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbamem.2006.05.027_bib38","doi-asserted-by":"crossref","first-page":"40262","DOI":"10.1074\/jbc.M305455200","article-title":"Ganglioside glycosyltransferases organize in distinct multienzyme complexes in CHO-K1 cells","volume":"278","author":"Giraudo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib39","doi-asserted-by":"crossref","first-page":"7044","DOI":"10.1073\/pnas.85.19.7044","article-title":"Both GA2-, GM2- and GD2 synthases and GM1b-, GD1a- and GT1b synthases are single enzymes in Golgi vesicles from rat liver","volume":"85","author":"Pohlentz","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib40","doi-asserted-by":"crossref","first-page":"25859","DOI":"10.1074\/jbc.R200001200","article-title":"Combinatorial ganglioside biosynthesis","volume":"277","author":"Kolter","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib41","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1073\/pnas.96.16.9142","article-title":"A vital role for glycosphingolipid synthesis during development differentiation","volume":"96","author":"Yamashita","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/B:GLYC.0000033627.02765.cc","article-title":"Ganglioside\/glycosphingolipid turnover: new concepts","volume":"20","author":"Tettamanti","year":"2004","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbamem.2006.05.027_bib43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/85879","article-title":"Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I","volume":"27","author":"Dawkins","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib44","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1172\/JCI0216450","article-title":"Hereditary sensory neuropathy type 1 mutations confer dominant negative effects on serine palmitoyltransferase, critical for sphingolipid synthesis","volume":"110","author":"Bejaoui","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamem.2006.05.027_bib45","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ng1460","article-title":"Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase","volume":"36","author":"Simpson","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib46","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1074\/jbc.M509483200","article-title":"The CLN9 Protein\u2014A regulator of dihydroceramide synthase","volume":"281","author":"Schulz","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.cellbio.21.122303.120013","article-title":"Principles of lysosomal membrane digestion\u2014Stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids","volume":"21","author":"Kolter","year":"2005","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm1315","article-title":"Endocytic recycling","volume":"5","author":"Maxfield","year":"2004","journal-title":"Nat. Rev., Mol. Cell Biol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2760(92)90210-M","article-title":"Activator proteins topology of lysosomal sphingolipid catabolism","volume":"1126","author":"F\u00fcrst","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2006.05.027_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0962-8924(03)00005-9","article-title":"At the acidic edge: emerging functions for lysosomal membrane proteins","volume":"13","author":"Eskelinen","year":"2003","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib51","first-page":"389","article-title":"GM1-gangliosidosis (generalized gangliosidosis) morphology chemical pathology","volume":"3","author":"Suzuki","year":"1968","journal-title":"Pathol. Eur."},{"key":"10.1016\/j.bbamem.2006.05.027_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF02024331","article-title":"Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient his fetal sibling: biochemical signs of combined sphingolipidoses","volume":"149","author":"Harzer","year":"1989","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bbamem.2006.05.027_bib53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0962-8924(96)80999-8","article-title":"Topologie of glycosphingolipid degradation","volume":"6","author":"Sandhoff","year":"1996","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib54","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/002215549904700804","article-title":"Intracellular distribution of a biotin-labeled ganglioside, GM1 by immunoelectron microscopy after endocytosis in fibroblasts","volume":"47","author":"Mobius","year":"1999","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/002215540205000105","article-title":"Immunoelectron microscopic localization of cholesterol using biotinylated non-cytolytic perfringolysin O","volume":"50","author":"Mobius","year":"2002","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib56","doi-asserted-by":"crossref","first-page":"35814","DOI":"10.1074\/jbc.M006568200","article-title":"Degradation of membrane-bound ganglioside GM1, stimulation by bis(monoacylglycero)phosphate the activator proteins SAP-B GM2-AP","volume":"275","author":"Wilkening","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib57","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1034\/j.1600-0854.2003.00072.x","article-title":"Recycling compartments the internal vesicles of multivesicular bodies harbor most of the cholesterol found in the endocytic pathway","volume":"4","author":"Mobius","year":"2003","journal-title":"Traffic"},{"key":"10.1016\/j.bbamem.2006.05.027_bib58","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1515\/bchm2.1979.360.2.1837","article-title":"Purification characterization of an activator protein for the degradation of glycolipids GM2 GA2 by hexosaminidase A","volume":"360","author":"Conzelmann","year":"1979","journal-title":"Hoppe Seylers Z. Physiol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib59","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1432-1327.1999.00302.x","article-title":"Interaction of the GM2-activator protein with phospholipid\u2013ganglioside bilayer membranes with monolayers at the air\u2013water interface","volume":"261","author":"Giehl","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib60","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1432-1033.2003.03964.x","article-title":"Photoaffinity labelling of the human GM2-activator protein. Mechanistic insight into ganglioside GM2 degradation","volume":"271","author":"Wendeler","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib61","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/pro.5560030219","article-title":"Acid sphingomyelinase possesses a domain homologous to its activator proteins: saposins B and D","volume":"3","author":"Ponting","year":"1994","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbamem.2006.05.027_bib62","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ni1035","article-title":"Saposin C is required for lipid presentation by human CD1b","volume":"5","author":"Winau","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ni1034","article-title":"Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells","volume":"5","author":"Kang","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib64","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1126\/science.1092009","article-title":"Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins","volume":"303","author":"Zhou","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbamem.2006.05.027_bib65","doi-asserted-by":"crossref","first-page":"13995","DOI":"10.1021\/bi961164o","article-title":"Transacylase phospholipases in the synthesis of bis(monoacylglycero)phosphate","volume":"35","author":"Amidon","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2006.05.027_bib66","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-2275(20)41698-0","article-title":"Subcellular distributions of lipids in cultured BHK cells: evidence for the enrichment of lysobisphosphatidic acid neutral lipids in lysosomes","volume":"18","author":"Brotherus","year":"1977","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbamem.2006.05.027_bib67","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1016\/S0021-9258(18)50510-X","article-title":"Degradation of bis(monoacylglycero)phosphate by an acid phosphodiesterase in rat liver lysosomes","volume":"254","author":"Matsuzawa","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib68","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/32440","article-title":"A lipid associated with the antiphospholipid syndrome regulates endosome structure function","volume":"392","author":"Kobayashi","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbamem.2006.05.027_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2510001","article-title":"The biological role of dolichol","volume":"251","author":"Chojnacki","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamem.2006.05.027_bib70","doi-asserted-by":"crossref","first-page":"12685","DOI":"10.1074\/jbc.M007970200","article-title":"Degradation of membrane-bound ganglioside GM2 by beta-hexosaminidase A: stimulation by GM2 activator protein and lysosomal lipids","volume":"276","author":"Werth","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib71","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1432-1033.1986.tb10071.x","article-title":"Specificity of human glucosylceramide beta-glucosidase towards synthetic glucosylsphingolipids inserted into liposomes. Kinetic studies in a detergent-free assay system","volume":"160","author":"Sarmientos","year":"1986","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(00)01417-4","article-title":"Further studies on the reconstitution of glucosylceramidase activity by Sap C anionic phospholipids","volume":"472","author":"Salvioli","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamem.2006.05.027_bib73","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.2004.05293.x","article-title":"Lysosomal storage disorders. B","volume":"128","author":"Vellodi","year":"2004","journal-title":"J. Haematol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib74","series-title":"Lysosomal Disorders of the Brain","first-page":"32","article-title":"Lysosomal defects storage","author":"Platt","year":"2004"},{"key":"10.1016\/j.bbamem.2006.05.027_bib75","series-title":"Lysosomal disorders of the brain","first-page":"81","article-title":"Primary defects in lysosomal enzymes","author":"Winchester","year":"2004"},{"key":"10.1016\/j.bbamem.2006.05.027_bib76","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"Futerman","year":"2004","journal-title":"Nat. Rev., Mol. Cell Biol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib77","series-title":"Greenfield's Neuropathology","first-page":"653","article-title":"Lysosomal diseases","author":"Suzuki","year":"2002"},{"key":"10.1016\/j.bbamem.2006.05.027_bib78","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bbamem.2006.05.027_bib79","first-page":"3371","article-title":"Sphingolipid activator proteins","volume":"vol. III","author":"Sandhoff","year":"2001"},{"key":"10.1016\/j.bbamem.2006.05.027_bib80","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1023\/B:GLYC.0000046272.38480.ef","article-title":"Glycosphingolipidoses: beyond the enzymatic defect","volume":"21","author":"Raas-Rothschild","year":"2004","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbamem.2006.05.027_bib81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1750-3639.1998.tb00138.x","article-title":"Recent advances in the biochemistry of sphingolipidoses","volume":"8","author":"Kolter","year":"1998","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib82","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1432-1033.1994.tb18844.x","article-title":"Hydrolysis of lactosylceramide by human galactosylceramidase GM1-beta-galactosidase in a detergent-free system its stimulation by sphingolipid activator proteins, sap-B sap-C. Activator proteins stimulate lactosylceramide hydrolysis","volume":"222","author":"Zschoche","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib83","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1750-3639.1998.tb00145.x","article-title":"Mouse models of human lysosomal diseases","volume":"8","author":"Suzuki","year":"1998","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib84","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/oxfordjournals.jbchem.a022101","article-title":"Induced mouse models of abnormal sphingolipid metabolism","volume":"124","author":"Suzuki","year":"1998","journal-title":"J. Biochem. (Tokyo)"},{"key":"10.1016\/j.bbamem.2006.05.027_bib85","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cccn.2004.11.035","article-title":"G(M1)-ganglioside degradation and biosynthesis in human and murine G(M1)-gangliosidosis","volume":"354","author":"Sano","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbamem.2006.05.027_bib86","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3775","article-title":"\u03b2-galactosidase deficiency (\u03b2-galactosidosis): GM1 gangliosidosis and morquio B disease","author":"Suzuki","year":"2001"},{"key":"10.1016\/j.bbamem.2006.05.027_bib87","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3811","article-title":"Galactosialidosis","author":"d'Azzo","year":"2001"},{"key":"10.1016\/j.bbamem.2006.05.027_bib88","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0079-6603(01)69045-7","article-title":"Lysosomal multienzyme complex: biochemistry, genetics, and molecular pathophysiology","volume":"69","author":"Pshezhetsky","year":"2001","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib89","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0006-3002(63)90764-9","article-title":"On a biochemically special form of infantile amaturotic idiocy","volume":"70","author":"Jatzkewitz","year":"1963","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2006.05.027_bib90","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1523\/JNEUROSCI.3635-05.2005","article-title":"Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1","volume":"25","author":"Wu","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamem.2006.05.027_bib91","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molcel.2004.08.029","article-title":"GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis","volume":"15","author":"del Tessitore","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamem.2006.05.027_bib92","first-page":"435","article-title":"Human beta-galactosidase gene mutations in GM1-gangliosidosis: a common mutation among Japanese adult\/chronic cases","volume":"49","author":"Yoshida","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib93","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/hmg\/6.2.205","article-title":"Generalized CNS disease massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase","volume":"6","author":"Hahn","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib94","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10545-005-0089-7","article-title":"Bone marrow transplantation correcting beta-galactosidase activity does not influence neurological outcome in juvenile GM1-gangliosidosis","volume":"28","author":"Shield","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbamem.2006.05.027_bib95","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1073\/pnas.2536657100","article-title":"Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis","volume":"100","author":"Matsuda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib96","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1194\/jlr.M400411-JLR200","article-title":"Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice","volume":"46","author":"Kasperzyk","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbamem.2006.05.027_bib97","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1096-7192(02)00199-3","article-title":"Imbalanced substrate specificity of mutant beta-galactosidase in patients with Morquio B disease","volume":"78","author":"Okumiya","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbamem.2006.05.027_bib98","first-page":"3827","article-title":"The GM2 Gangliosidoses","volume":"vol. III","author":"Gravel","year":"2001"},{"key":"10.1016\/j.bbamem.2006.05.027_bib99","series-title":"The Metabolic Bases of Inherited Disease","first-page":"1807","article-title":"The GM2 gangliosidoses","author":"Sandhoff","year":"1989"},{"key":"10.1016\/j.bbamem.2006.05.027_bib100","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1016\/S0021-9258(17)39645-X","article-title":"Evidence for two different active sites on human beta-hexosaminidase A, Interaction of GM2 activator protein with beta-hexosaminidase A","volume":"260","author":"Kytzia","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib101","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0022-2836(03)00311-5","article-title":"The X-ray crystal structure of human beta-hexosaminidase B provides new insights into Sandhoff disease","volume":"328","author":"Maier","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib102","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0022-2836(03)00216-X","article-title":"Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff Tay\u2013Sachs disease","volume":"327","author":"Mark","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib103","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1074\/jbc.M105457200","article-title":"Physiological substrates for human lysosomal beta-hexosaminidase S","volume":"277","author":"Hepbildikler","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib104","first-page":"466","article-title":"Tay Sachs disease","volume":"61","author":"Filho","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib105","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/j.1460-2075.1983.tb01567.x","article-title":"Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity","volume":"2","author":"Kytzia","year":"1983","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamem.2006.05.027_bib106","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000112175","article-title":"Biochemical molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype","volume":"13","author":"Suzuki","year":"1991","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.bbamem.2006.05.027_bib107","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1111\/j.1471-4159.1971.tb00204.x","article-title":"Enzyme alterations lipid storage in three variants of Tay\u2013Sachs disease","volume":"18","author":"Sandhoff","year":"1971","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib108","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1073\/pnas.75.8.3979","article-title":"AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 glycolipid GA2","volume":"75","author":"Conzelmann","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib109","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/j.1471-4159.2005.02986.x","article-title":"Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates","volume":"92","author":"Tsuji","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1515\/bchm3.1986.367.1.241","article-title":"Occurrence of lysoganglioside lyso-GM2 (II3-Neu5Ac-gangliotriaosyl-sphingosine) in GM2 gangliosidosis brain","volume":"367","author":"Neuenhofer","year":"1986","journal-title":"Biol. Chem. Hoppe-Seyler"},{"key":"10.1016\/j.bbamem.2006.05.027_bib111","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/j.1471-4159.1992.tb08460.x","article-title":"Accumulation of lysosphingolipids in tissues from patients with GM1 GM2 gangliosidoses","volume":"59","author":"Kobayashi","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib112","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1172\/JCI2127","article-title":"Bone marrow transplantation prolongs life span ameliorates neurologic manifestations in Sandhoff disease mice","volume":"101","author":"Norflus","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamem.2006.05.027_bib113","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng1095-170","article-title":"Mouse models of Tay\u2013Sachs Sandhoff diseases differ in neurologic phenotype ganglioside metabolism","volume":"11","author":"Sango","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib114","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/nbdi.2002.0511","article-title":"An inducible mouse model of late onset Tay\u2013Sachs disease","volume":"10","author":"Jeyakumar","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbamem.2006.05.027_bib115","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3733","article-title":"\u03b1-Galactosidase a deficiency fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.bbamem.2006.05.027_bib116","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10545-005-0039-4","article-title":"The ratio of alpha-galactosidase to beta-glucuronidase activities in dried blood for the identification of female Fabry disease patients","volume":"28","author":"Lukacs","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbamem.2006.05.027_bib117","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"alpha-Galactosidase A deficient mice: a model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib118","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1073\/pnas.0537900100","article-title":"Long-term correction of globotriaosylceramide storage in Fabry mice by recombinant adenoassociated virus-mediated gene transfer","volume":"100","author":"Park","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib119","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bbamem.2006.05.027_bib120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamem.2006.05.027_bib121","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJM200107053450104","article-title":"Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy","volume":"345","author":"Frustaci","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamem.2006.05.027_bib122","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","article-title":"Accelerated transport maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor","volume":"5","author":"Fan","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamem.2006.05.027_bib123","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1046\/j.1432-1327.2000.01457.x","article-title":"In vitro inhibition and intracellular enhancement of lysosomal alpha-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives","volume":"267","author":"Asano","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib124","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1096\/fj.04-2375com","article-title":"A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder","volume":"19","author":"Yam","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamem.2006.05.027_bib125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bbadis.2004.07.001","article-title":"Transgenic mouse expressing human mutant alpha-galactosidase A in an endogenous enzyme deficient background: a biochemical animal model for studying active-site specific chaperone therapy for Fabry disease","volume":"1690","author":"Ishii","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2006.05.027_bib126","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00018-002-8458-y","article-title":"Gaucher disease: perspectives on a prototype lysosomal disease","volume":"59","author":"Zhao","year":"2002","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.bbamem.2006.05.027_bib127","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","article-title":"Gaucher disease: pathological mechanisms and modern management","volume":"129","author":"Jmoudiak","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib128","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher's disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamem.2006.05.027_bib129","doi-asserted-by":"crossref","first-page":"17C","DOI":"10.1042\/bj0970017C","article-title":"Short communications: a deficiency of glucocerebrosidase in Gaucher's disease","volume":"97","author":"Patrick","year":"1965","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamem.2006.05.027_bib130","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3635","article-title":"Gaucher Disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.bbamem.2006.05.027_bib131","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/sj.embor.embor873","article-title":"X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease","volume":"4","author":"Dvir","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbamem.2006.05.027_bib132","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M502799200","article-title":"X-ray structure of human acid \u03b2-glucosidase covalently-bound to conduritol-\u03b2-epoxide: implications for Gaucher disease","author":"Premkumar","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib133","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1074\/jbc.M511110200","article-title":"Analyses of variant acid beta-glucosidases: effects of gaucher disease mutations","volume":"281","author":"Liou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib134","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0005-2760(81)90134-X","article-title":"Mechanism of activation of glucocerebrosidase by co-beta-glucosidase (glucosidase activator protein)","volume":"664","author":"Berent","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2006.05.027_bib135","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1016\/S0021-9258(18)98580-7","article-title":"Human acid beta-glucosidase. Use of inhibitory activating monoclonal antibodies to investigate the enzyme's catalytic mechanism saposin A C binding sites","volume":"266","author":"Fabbro","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib136","doi-asserted-by":"crossref","first-page":"16862","DOI":"10.1074\/jbc.272.27.16862","article-title":"Effect of saposins A C on the enzymatic hydrolysis of liposomal glucosylceramide","volume":"272","author":"Vaccaro","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib137","doi-asserted-by":"crossref","first-page":"30271","DOI":"10.1074\/jbc.273.46.30271","article-title":"Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids activators","volume":"273","author":"Wilkening","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib138","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/adc.63.7.854","article-title":"Collodion babies with Gaucher's disease","volume":"63","author":"Liu","year":"1988","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.bbamem.2006.05.027_bib139","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj3030377","article-title":"Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-d-erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity the type of Gaucher disease","volume":"303","author":"Meivar-Levy","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamem.2006.05.027_bib140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/bcmd.1997.0137","article-title":"Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease","volume":"23","author":"Hollak","year":"1997","journal-title":"Blood Cells Mol., Diseases"},{"key":"10.1016\/j.bbamem.2006.05.027_bib141","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1203\/00006450-200008000-00018","article-title":"Glucosylsphingosine accumulation in mice patients with type 2 Gaucher disease begins early in gestation","volume":"48","author":"Orvisky","year":"2000","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bbamem.2006.05.027_bib142","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI0214530","article-title":"Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage","volume":"109","author":"Mizukami","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamem.2006.05.027_bib143","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamem.2006.05.027_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01233949","article-title":"Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency","volume":"19","author":"Rafi","year":"1993","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/BJ20050325","article-title":"The N370S mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and Saposin C","volume":"390","author":"Salvioli","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamem.2006.05.027_bib146","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/357407a0","article-title":"Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene","volume":"357","author":"Tybulewicz","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bbamem.2006.05.027_bib147","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib148","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1098\/rstb.2003.1269","article-title":"Enzyme replacement therapy: conception, chaos and culmination","volume":"358","author":"Brady","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond., B"},{"key":"10.1016\/j.bbamem.2006.05.027_bib149","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1073\/pnas.87.5.1913","article-title":"Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease","volume":"87","author":"Barton","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib150","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1212\/01.WNL.0000130191.31669.48","article-title":"Deterioration of the auditory brainstem response in children with type 3 Gaucher disease","volume":"63","author":"Campbell","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbamem.2006.05.027_bib151","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(87)91673-4","article-title":"Beneficial effect of pre-transplant splenectomy on displacement bone marrow transplantation for Gaucher's syndrome","volume":"1","author":"Hobbs","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.bbamem.2006.05.027_bib152","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1651-2227.1990.tb11535.x","article-title":"Clinical and biochemical outcome of marrow transplantation for Gaucher disease of the Norrbottnian type","volume":"79","author":"Erikson","year":"1990","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.bbamem.2006.05.027_bib153","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00007890-199503000-00011","article-title":"Ten years' experience of bone marrow transplantation for Gaucher disease","volume":"59","author":"Ringden","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.bbamem.2006.05.027_bib154","first-page":"77","article-title":"Secondary G-CSF mobilized blood stem cell transplantation without preconditioning in a patient with Gaucher disease: report of a new approach which resulted in complete reversal of severe skeletal involvement","volume":"30","author":"Yabe","year":"2005","journal-title":"Tokai J. Exp. Clin. Med."},{"key":"10.1016\/j.bbamem.2006.05.027_bib155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1651-2227.2003.tb00225.x","article-title":"Metachromatic leukodystrophy: consequences of sulphatide accumulation","volume":"443","author":"Gieselmann","year":"2003","journal-title":"Acta Paedriatr., Suppl."},{"key":"10.1016\/j.bbamem.2006.05.027_bib156","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/08830738030180090301","article-title":"Metachromatic leukodystrophy: recent research developments","volume":"18","author":"Gieselmann","year":"2003","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib157","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3695","article-title":"Metachromatic leukodystrophy","author":"von Figura","year":"2001"},{"key":"10.1016\/j.bbamem.2006.05.027_bib158","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1515\/bchm2.1964.339.1.260","article-title":"A cerebrosidesulfatase from swine kidney","volume":"339","author":"Mehl","year":"1964","journal-title":"Hoppe-Seylers Z. Physiol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib159","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1056\/NEJM199101033240104","article-title":"Molecular basis of different forms of metachromatic leukodystrophy","volume":"324","author":"Polten","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamem.2006.05.027_bib160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00230227","article-title":"Prevalence of common mutations in the arylsulphatase A gene in metachromatic leukodystrophy patients diagnosed in Britain","volume":"91","author":"Barth","year":"1993","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib161","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/BF02072213","article-title":"Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, immunological study","volume":"150","author":"Schlote","year":"1991","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bbamem.2006.05.027_bib162","doi-asserted-by":"crossref","first-page":"14821","DOI":"10.1073\/pnas.93.25.14821","article-title":"Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy","volume":"93","author":"Hess","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib163","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/hmg\/ddi126","article-title":"Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy","volume":"14","author":"Matzner","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib164","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/088307389901400402","article-title":"Slow progression of juvenile metachromatic leukodystrophy 6 years after bone marrow transplantation","volume":"14","author":"Kapaun","year":"1999","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib165","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1172\/JCI200419205","article-title":"Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells","volume":"113","author":"Biffi","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamem.2006.05.027_bib166","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3725","article-title":"Multiple sulfatase deficiency and the nature of the sulfatase family","author":"Hopwood","year":"2001"},{"key":"10.1016\/j.bbamem.2006.05.027_bib167","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0092-8674(95)90314-3","article-title":"A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency","volume":"82","author":"Schmidt","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bbamem.2006.05.027_bib168","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0092-8674(03)00347-7","article-title":"Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme","volume":"113","author":"Dierks","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bbamem.2006.05.027_bib169","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1073\/pnas.66.2.302","article-title":"Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase","volume":"66","author":"Suzuki","year":"1970","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib170","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3669","article-title":"Galactosylceramide lipidosis: globoid cell leukodystrophy (Krabbe disease)","author":"Wenger","year":"2001"},{"key":"10.1016\/j.bbamem.2006.05.027_bib171","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/hmg\/4.8.1285","article-title":"A large deletion together with a point mutation in the GALC gene is a common mutant allele in patients with infantile Krabbe disease","volume":"4","author":"Rafi","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib172","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s004150070076","article-title":"Deletion of exons 11\u201317 novel mutations of the galactocerebrosidase gene in adult-early-onset patients with Krabbe disease","volume":"247","author":"Selleri","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib173","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1046\/j.1471-4159.1996.66031118.x","article-title":"Molecular cloning expression of cDNA for murine galactocerebrosidase mutation analysis of the twitcher mouse, a model of Krabbe's disease","volume":"66","author":"Sakai","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib174","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/mgme.2001.3194","article-title":"Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease)","volume":"73","author":"Luzi","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbamem.2006.05.027_bib175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-5728(96)00166-X","article-title":"IL-6 and TNF\u03b1 expression in brains of twitcher, quaking and normal mice","volume":"73","author":"LeVine","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib176","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1006\/exnr.1999.7125","article-title":"IL-6 deficiency causes enhanced pathology in twitcher (globoid cell leukodystrophy) mice","volume":"158","author":"Pedchenko","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib177","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/(SICI)1097-4547(20000115)59:2<170::AID-JNR3>3.0.CO;2-G","article-title":"Biochemistry and neuropathology of mice doubly deficient in synthesis and degradation of galactosylceramide","volume":"59","author":"Ezoe","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbamem.2006.05.027_bib178","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamem.2006.05.027_bib179","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1096\/fj.05-3826fje","article-title":"Enzyme replacement therapy results in substantial improvements in early clinical phenotype in a mouse model of globoid cell leukodystrophy","volume":"19","author":"Lee","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamem.2006.05.027_bib180","first-page":"3611","article-title":"Niemann\u2013Pick disease type C: a lipid trafficking disorder","volume":"vol. III","author":"Patterson","year":"2001"},{"key":"10.1016\/j.bbamem.2006.05.027_bib181","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.nrl.0000094627.78754.5b","article-title":"A riddle wrapped in a mystery: understanding Niemann\u2013Pick disease, type C","volume":"9","author":"Patterson","year":"2003","journal-title":"Neurolog."},{"key":"10.1016\/j.bbamem.2006.05.027_bib182","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/bchm3.1994.375.7.447","article-title":"The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts","volume":"375","author":"Hurwitz","year":"1994","journal-title":"Biol. Chem. Hoppe-Seyler"},{"key":"10.1016\/j.bbamem.2006.05.027_bib183","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0014-5793(04)00033-X","article-title":"Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine","volume":"559","author":"Koelzer","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamem.2006.05.027_bib184","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3589","article-title":"Niemann\u2013Pick disease types A B: acid sphingomyelinase deficiencies","author":"Schuchman","year":"2001"},{"key":"10.1016\/j.bbamem.2006.05.027_bib185","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1046\/j.1432-1033.2003.03435.x","article-title":"Human acid sphingomyelinase","volume":"270","author":"Lansmann","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib186","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1515\/BC.2001.035","article-title":"Stimulation of acid sphingomyelinase activity by lysosomal lipids sphingolipid activator proteins","volume":"382","author":"Linke","year":"2001","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib187","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1046\/j.1471-4159.1994.63031060.x","article-title":"Accurate differentiation of neuronopathic nonneuronopathic forms of Niemann\u2013Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells","volume":"63","author":"Graber","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib188","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/bj20021528","article-title":"Ceramide: second messenger or modulator of membrane structure dynamics?","volume":"369","author":"van Blitterswijk","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamem.2006.05.027_bib189","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.4049\/jimmunol.170.5.2621","article-title":"Severe impairment in early host defense against Listeria monocytogenes in mice deficient in acid sphingomyelinase","volume":"170","author":"Uterm\u00f6hlen","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib190","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1139\/o88-153","article-title":"Lysosphingolipids mitochondrial function. II. Deleterious effects of sphingosylphosphorylcholine","volume":"66","author":"Strasberg","year":"1988","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib191","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ng0795-288","article-title":"Acid sphingomyelinase deficient mice: a model of types A B Niemann\u2013Pick disease","volume":"10","author":"Horinouchi","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib192","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0092-8674(05)80010-8","article-title":"Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann\u2013Pick disease)","volume":"81","author":"Otterbach","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bbamem.2006.05.027_bib193","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/bmj.295.6610.1375","article-title":"Treatment of Niemann\u2013Pick disease type B by allogeneic bone marrow transplantation","volume":"295","author":"Vellodi","year":"1987","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.bbamem.2006.05.027_bib194","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/BF01800234","article-title":"Bone marrow transplantation for Niemann\u2013Pick type IA disease","volume":"15","author":"Bayever","year":"1992","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbamem.2006.05.027_bib195","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3573","article-title":"Acid ceramidase deficiency: farber lipogranulomatosis","author":"Moser","year":"2001"},{"key":"10.1016\/j.bbamem.2006.05.027_bib196","doi-asserted-by":"crossref","first-page":"11098","DOI":"10.1074\/jbc.270.19.11098","article-title":"Purification, characterization, biosynthesis of human acid ceramidase","volume":"270","author":"Bernardo","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib197","doi-asserted-by":"crossref","first-page":"33110","DOI":"10.1074\/jbc.271.51.33110","article-title":"Molecular cloning characterization of a full-length complementary DNA encoding human acid ceramidase. Identification of the first molecular lesion causing Farber disease","volume":"271","author":"Koch","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib198","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1074\/jbc.M006846200","article-title":"Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids sphingolipid activator proteins","volume":"276","author":"Linke","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib199","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1006\/bbrc.1994.1612","article-title":"Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo","volume":"200","author":"Klein","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamem.2006.05.027_bib200","doi-asserted-by":"crossref","first-page":"29948","DOI":"10.1074\/jbc.M303310200","article-title":"The reverse activity of human acid ceramidase","volume":"278","author":"Okino","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib201","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/humu.5","article-title":"Molecular analysis of acid ceramidase deficiency in patients with Farber disease","volume":"17","author":"B\u00e4r","year":"2001","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbamem.2006.05.027_bib202","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/geno.2002.6686","article-title":"Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes","volume":"79","author":"Li","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.bbamem.2006.05.027_bib203","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1023\/A:1005590316064","article-title":"Ceramide accumulation is associated with increased apoptotic cell death in cultured fibroblasts of sphingolipid activator protein-deficient mouse but not in fibroblasts of patients with Farber disease","volume":"22","author":"Tohyama","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbamem.2006.05.027_bib204","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0022-510X(95)00231-0","article-title":"Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells","volume":"134","author":"Levade","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbamem.2006.05.027_bib205","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bmt.1702489","article-title":"Bone marrow transplantation for infantile ceramidase deficiency (Farber disease)","volume":"26","author":"Yeager","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbamem.2006.05.027_bib206","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1515\/bchm3.1988.369.1.317","article-title":"The precursor of sulfatide activator protein is processed to three different proteins","volume":"369","author":"F\u00fcrst","year":"1988","journal-title":"Biol. Chem. Hoppe-Seyler"},{"key":"10.1016\/j.bbamem.2006.05.027_bib207","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.2842863","article-title":"Coding of two sphingolipid activator proteins (SAP-1 SAP-2) by same genetic locus","volume":"241","author":"O'Brien","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bbamem.2006.05.027_bib208","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/oxfordjournals.jbchem.a122629","article-title":"Structure of full-length cDNA coding for sulfatide activator, a Co-beta-glucosidase two other homologous proteins: two alternate forms of the sulfatide activator","volume":"105","author":"Nakano","year":"1989","journal-title":"J. Biochem. (Tokyo)"},{"key":"10.1016\/j.bbamem.2006.05.027_bib209","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00219682","volume":"92","author":"Bradova","year":"1993","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib210","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1016\/S0021-9258(19)50733-5","article-title":"Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene.","volume":"267","author":"Schnabel","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib211","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2005-865608","article-title":"Prosaposin deficiency\u2014A rarely diagnosed, rapidly progressing, neonatal neurovisceral lipid storage disease. Report of a further patient","volume":"36","author":"Elleder","year":"2005","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.bbamem.2006.05.027_bib212","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/hmg\/10.9.927","article-title":"A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin saposins, is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation","volume":"10","author":"Hulkova","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib213","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/hmg\/5.6.711","article-title":"Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy wide-spread storage of multiple sphingolipids","volume":"5","author":"Fujita","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib214","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/hmg\/10.11.1191","article-title":"A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse","volume":"10","author":"Matsuda","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib215","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymgme.2004.10.004","article-title":"A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans","volume":"84","author":"Spiegel","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbamem.2006.05.027_bib216","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1432-1033.1991.tb16222.x","article-title":"Glycosphingolipid specificity of the human sulfatide activator protein","volume":"200","author":"Vogel","year":"1991","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib217","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1016\/S0021-9258(18)68681-8","article-title":"Characterization of a nonspecific activator protein for the enzymatic hydrolysis of glycolipids","volume":"263","author":"Li","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib218","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0021-9258(18)89673-9","volume":"260","author":"Li","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib219","series-title":"Lipid Storage Disorders","first-page":"323","article-title":"The physiological roles of activator proteins for lysosomal glycolipid degradation","author":"Conzelmann","year":"1988"},{"key":"10.1016\/j.bbamem.2006.05.027_bib220","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1073\/pnas.0136947100","article-title":"Crystal structure of saposin B reveals a dimeric shell for lipid binding","volume":"100","author":"Ahn","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib221","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1073\/pnas.87.7.2541","article-title":"Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect","volume":"87","author":"Kretz","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib222","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1073\/pnas.68.11.2810","article-title":"Gaucher's disease: deficiency of \u2018acid\u2019 beta-glucosidase reconstitution of enzyme activity in vitro","volume":"68","author":"Ho","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib223","doi-asserted-by":"crossref","first-page":"31918","DOI":"10.1074\/jbc.M302752200","article-title":"Saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradation","volume":"278","author":"Sun","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib224","doi-asserted-by":"crossref","first-page":"14729","DOI":"10.1021\/bi0301338","article-title":"Solution structure of human saposin C: pH-dependent interaction with phospholipid vesicles","volume":"42","author":"de Alba","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2006.05.027_bib225","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1515\/bchm3.1986.367.2.879","article-title":"Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant","volume":"367","author":"Christomanou","year":"1986","journal-title":"Biol. Chem. Hoppe-Seyler"},{"key":"10.1016\/j.bbamem.2006.05.027_bib226","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(91)80760-Z","article-title":"Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease","volume":"284","author":"Schnabel","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamem.2006.05.027_bib227","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00439-005-1288-x","article-title":"A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity","volume":"117","author":"Diaz-Font","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib228","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/hmg\/ddh281","article-title":"Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse","volume":"13","author":"Matsuda","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"447","key":"10.1016\/j.bbamem.2006.05.027_bib229","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/08035320510028210","article-title":"What can cell biology tell us about heterogeneity in lysosomal storage diseases?","volume":"94","author":"Gieselmann","year":"2005","journal-title":"Acta Paediatr., Suppl."},{"key":"10.1016\/j.bbamem.2006.05.027_bib230","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000112332","article-title":"Partial enzyme deficiencies: residual activities the development of neurological disorders","volume":"6","author":"Conzelmann","year":"1983","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.bbamem.2006.05.027_bib231","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF00219337","article-title":"Quantitative correlation between the residual activity of beta-hexosaminidase A arylsulfatase A the severity of the resulting lysosomal storage disease","volume":"88","author":"Leinekugel","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib232","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0344-0338(11)80422-X","article-title":"Lysosomal storage diseases in adults","volume":"190","author":"Rapola","year":"1994","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbamem.2006.05.027_bib233","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1242\/jcs.113.9.1515","article-title":"Lysosome\u2013endosome fusion and lysosome biogenesis","volume":"113","author":"Luzio","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbamem.2006.05.027_bib234","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(01)00421-4","article-title":"Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes","volume":"106","author":"Reddy","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bbamem.2006.05.027_bib235","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbrc.2004.12.054","article-title":"Exocytosis of storage material in a lysosomal disorder","volume":"327","author":"Klein","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamem.2006.05.027_bib236","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00005072-199906000-00009","article-title":"An apoptotic depletion of oligodendrocytes in the twitcher, a murine model of globoid cell leukodystrophy","volume":"58","author":"Taniike","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib237","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/(SICI)1096-8628(20000320)91:3<222::AID-AJMG13>3.0.CO;2-#","article-title":"Severe type II Gaucher disease with ichthyosis, arthrogryposis neuronal apoptosis: molecular pathological analyses","volume":"91","author":"Finn","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib238","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1651-2227.2003.tb00222.x","article-title":"Sequelae of storage in Fabry disease-pathology and comparison with other lysosomal storage diseases","volume":"443","author":"Elleder","year":"2003","journal-title":"Acta Paediatr., Suppl."},{"key":"10.1016\/j.bbamem.2006.05.027_bib239","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0006-291X(72)90381-6","article-title":"Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase","volume":"48","author":"Miyatake","year":"1972","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamem.2006.05.027_bib240","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1083\/jcb.153.2.429","article-title":"Identification of a molecular target of psychosine its role in globoid cell formation","volume":"153","author":"Im","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib241","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1083\/jcb.149.4.943","article-title":"Inhibition of Cytokinesis by a Lipid Metabolite, Psychosine","volume":"149","author":"Kanazawa","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib242","first-page":"161","article-title":"Effect of psychosine on mitochondrial function","volume":"35","author":"Tapasi","year":"1998","journal-title":"Indian J. Biochem. Biophys."},{"key":"10.1016\/j.bbamem.2006.05.027_bib243","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1471-4159.1982.tb07950.x","article-title":"Accumulation of glucosylceramide glucosylsphingosine (psychosine) in cerebrum cerebellum in infantile juvenile Gaucher disease","volume":"39","author":"Nilsson","year":"1982","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib244","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.1471-4159.1990.tb04942.x","article-title":"Lysosulfatide (sulfogalactosylsphingosine) accumulation in tissues from patients with metachromatic leukodystrophy","volume":"55","author":"Toda","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib245","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1022501702403","article-title":"Sphingosylphosphorylcholine in Niemann\u2013Pick disease brain: accumulation in type A but not in type B","volume":"24","author":"Rodriguez-Lafrasse","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbamem.2006.05.027_bib246","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(76)90245-6","article-title":"Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease","volume":"116","author":"Purpura","year":"1976","journal-title":"Brain Res."},{"key":"10.1016\/j.bbamem.2006.05.027_bib247","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1750-3639.1998.tb00144.x","article-title":"Cellular pathology of lysosomal storage disorders","volume":"8","author":"Walkley","year":"1998","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib248","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.97.20.10954","article-title":"Microglial activation precedes acute neurodegeneration in Sandhoff disease is suppressed by bone marrow transplantation","volume":"97","author":"Wada","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib249","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/brain\/awg089","article-title":"Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 GM2 gangliosidosis","volume":"126","author":"Jeyakumar","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.bbamem.2006.05.027_bib250","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1073\/pnas.0400625101","article-title":"Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice","volume":"101","author":"Wu","year":"2004","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib251","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0962-8924(03)00033-3","article-title":"Storage diseases: new insights into sphingolipid functions","volume":"13","author":"Sillence","year":"2003","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib252","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(98)10034-X","article-title":"Broad screening test for sphingolipid storage diseases","volume":"354","author":"Chen","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bbamem.2006.05.027_bib253","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1074\/jbc.274.31.21673","article-title":"Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons","volume":"274","author":"Korkotian","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib254","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.semcdb.2004.03.003","article-title":"The pathogenesis of glycosphingolipid storage disorders","volume":"15","author":"Ginzburg","year":"2004","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib255","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2004.01.011","article-title":"Fabry disease: reduced activities of respiratory chain enzymes with decreased levels of energy-rich phosphates in fibroblasts","volume":"82","author":"Lucke","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbamem.2006.05.027_bib256","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0076-6879(87)38063-2","article-title":"Enzymatic diagnosis of sphingolipidoses","volume":"138","author":"Suzuki","year":"1987","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib257","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nrg963","article-title":"Enzyme replacement and enhancement therapies: lessons from lysosomal disorders","volume":"3","author":"Desnick","year":"2002","journal-title":"Nat. Rev., Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib258","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrg1772","article-title":"Storage solutions: treating lysosomal disorders of the brain","volume":"6","author":"Jeyakumar","year":"2005","journal-title":"Nat. Rev., Neurosci."},{"key":"10.1016\/j.bbamem.2006.05.027_bib259","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/cbic.200390045","article-title":"Chemical chaperones\u2014A new concept in drug research","volume":"4","author":"Kolter","year":"2003","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bbamem.2006.05.027_bib260","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0165-6147(03)00158-5","article-title":"A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity","volume":"24","author":"Fan","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbamem.2006.05.027_bib261","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.276.5311.428","article-title":"Prevention of lysosomal storage in Tay\u2013Sachs mice treated with N-butyldeoxynojirimycin","volume":"276","author":"Platt","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbamem.2006.05.027_bib262","series-title":"Lysosomal Disorders of the Brain","first-page":"327","article-title":"Enzyme replacement therapy","author":"Neufeld","year":"2004"},{"key":"10.1016\/j.bbamem.2006.05.027_bib263","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/B:BOLI.0000031101.12838.c6","article-title":"Enzyme replacement and enhancement therapies for lysosomal diseases","volume":"27","author":"Desnick","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbamem.2006.05.027_bib264","series-title":"Lysosomal Disorders of the Brain","first-page":"339","article-title":"Cell-mediated delivery system","author":"Dobrenis","year":"2004"},{"key":"10.1016\/j.bbamem.2006.05.027_bib265","doi-asserted-by":"crossref","first-page":"10642","DOI":"10.1523\/JNEUROSCI.3584-04.2004","article-title":"Intracerebral transplantation of adult mouse neural progenitor cells into the Niemann\u2013Pick-A mouse leads to a marked decrease in lysosomal storage pathology","volume":"24","author":"Shihabuddin","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamem.2006.05.027_bib266","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1523\/JNEUROSCI.22-15-06437.2002","article-title":"Distribution of a lysosomal enzyme in the adult brain by axonal transport and by cells of the rostral migratory stream","volume":"22","author":"Passini","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamem.2006.05.027_bib267","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00062752-199911000-00004","article-title":"Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome","volume":"6","author":"Krivit","year":"1999","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib268","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00019052-199904000-00007","volume":"12","author":"Krivit","year":"1999","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib269","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1172\/JCI113521","article-title":"Effect of bone marrow transplantation on enzyme levels clinical course in the neurologically affected twitcher mouse","volume":"81","author":"Hoogerbrugge","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamem.2006.05.027_bib270","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1182\/blood.V78.11.3081.3081","article-title":"Increased life span correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation","volume":"78","author":"Birkenmeier","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbamem.2006.05.027_bib271","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00281-004-0166-2","article-title":"Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases","volume":"26","author":"Krivit","year":"2004","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib272","series-title":"Lysosomal Disorders of the Brain","first-page":"409","article-title":"Gene therapy","author":"Sands","year":"2004"},{"key":"10.1016\/j.bbamem.2006.05.027_bib273","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1089\/hum.2005.16.1133","article-title":"Gene therapy of storage disorders by retroviral and lentiviral vectors","volume":"16","author":"Biffi","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbamem.2006.05.027_bib274","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jgm.581","article-title":"Gene therapy for lysosomal storage diseases: the lessons and promise of animal models","volume":"6","author":"Ellinwood","year":"2004","journal-title":"J. Gene Med."},{"key":"10.1016\/j.bbamem.2006.05.027_bib275","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1006\/bbrc.1996.0136","article-title":"Correction of the galactocerebrosidase deficiency in globoid cell leukodystrophy-cultured cells by SL3-3 retroviral-mediated gene transfer","volume":"218","author":"Gama Sosa","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamem.2006.05.027_bib276","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.nbd.2005.04.017","article-title":"Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts","volume":"20","author":"Arfi","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbamem.2006.05.027_bib277","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1073\/pnas.94.4.1287","article-title":"Adenovirus-mediated gene transfer expression of human beta-glucuronidase gene in the liver, spleen, central nervous system in mucopolysaccharidosis type VII mice","volume":"94","author":"Ohashi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib278","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1128\/JVI.73.4.3424-3429.1999","article-title":"Systemic central nervous system correction of lysosomal storage in mucopolysaccharidosis type VII mice","volume":"73","author":"Stein","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib279","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/hmg\/ddi216","article-title":"A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay\u2013Sachs disease","volume":"14","author":"Martino","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamem.2006.05.027_bib280","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/sj.gt.3302081","article-title":"Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector mannitol","volume":"10","author":"Bourgoin","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbamem.2006.05.027_bib281","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0074-7696(05)23002-4","article-title":"Endoplasmic reticulum associated protein degradation","volume":"223","author":"Jarosch","year":"2003","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib282","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2006.05.027_bib283","doi-asserted-by":"crossref","first-page":"13478","DOI":"10.1074\/jbc.M308523200","article-title":"Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay\u2013Sachs and Sandhoff Patients","volume":"279","author":"Tropak","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2006.05.027_bib284","doi-asserted-by":"crossref","first-page":"43R","DOI":"10.1093\/glycob\/cwi076","article-title":"Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses","volume":"15","author":"Butters","year":"2005","journal-title":"Glycobiology"},{"issue":"447","key":"10.1016\/j.bbamem.2006.05.027_bib285","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/08035320510028157","volume":"94","author":"Cox","year":"2005","journal-title":"Acta Paediatr., Suppl."},{"key":"10.1016\/j.bbamem.2006.05.027_bib286","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI5542","article-title":"A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder","volume":"103","author":"Liu","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamem.2006.05.027_bib287","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbamem.2006.05.027_bib288","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/B:BOLI.0000045756.54006.17","article-title":"Sustained therapeutic effects of oral miglustat (Zavesca, Nbutyldeoxynojirimycin, OGT, 918) in type I Gaucher disease","volume":"27","author":"Elstein","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbamem.2006.05.027_bib289","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.nbd.2004.04.012","article-title":"Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease","volume":"16","author":"Andersson","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbamem.2006.05.027_bib290","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ana.20242","article-title":"NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin","volume":"56","author":"Jeyakumar","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamem.2006.05.027_bib291","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1097-4547(20000415)60:2<231::AID-JNR12>3.0.CO;2-E","article-title":"l-cycloserine slows the clinical and pathological course in mice with globoid cell leukodystrophy (twitcher mice)","volume":"60","author":"LeVine","year":"2000","journal-title":"J. Neurosci. Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273606002069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273606002069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T21:12:25Z","timestamp":1707081145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0005273606002069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":291,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0005273606002069"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamem.2006.05.027","relation":{},"ISSN":["0005-2736"],"issn-type":[{"value":"0005-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}